Payer Policy Changes for Billing Teams

Policy	Payer	Type	Specialty	Date
Speech Generating Devices — NCD 274 \| CMS Coverage Update	CMS	Modified	DME & Home Health	Mar 12, 2026
Multiple Electroconvulsive Therapy (MECT) — NCD 278 \| CMS Coverage Update	CMS	Modified	Behavioral Health	Mar 12, 2026
Deep Brain Stimulation for Essential Tremor and Parkinson’s Disease — NCD 279 \| CMS Coverage Update	CMS	Modified	Neurology & Neurosurgery	Mar 12, 2026
Treatment of Drug Abuse (Chemical Dependency) — NCD 28 \| CMS Coverage Update	CMS	Modified	Pharmacy	Mar 12, 2026
Intestinal and Multi-Visceral Transplantation — NCD 280 \| CMS Coverage Update	CMS	Modified	General Surgery	Mar 12, 2026
Colorectal Cancer Screening Tests — NCD 281 \| CMS Coverage Update	CMS	Modified	Oncology, Primary Care	Mar 12, 2026
Acupuncture for Fibromyalgia — NCD 283 \| CMS Coverage Update	CMS	Modified	Rheumatology	Mar 12, 2026
Acupuncture for Osteoarthritis — NCD 284 \| CMS Coverage Update	CMS	Modified	Rheumatology	Mar 12, 2026
Arthroscopic Lavage and Arthroscopic Debridement for the Osteoarthritic Knee — NCD 285 \| CMS Coverage Update	CMS	Modified	Orthopedics & Spine	Mar 12, 2026
Islet Cell Transplantation in the Context of a Clinical Trial — NCD 286 \| CMS Coverage Update	CMS	Modified	Endocrinology	Mar 12, 2026
FDG PET for Dementia and Neurodegenerative Diseases — NCD 288 \| CMS Coverage Update	CMS	Modified	Neurology & Neurosurgery	Mar 12, 2026
Treatment of Alcoholism and Drug Abuse in a Freestanding Clinic — NCD 29 \| CMS Coverage Update	CMS	Modified	Pharmacy	Mar 12, 2026
Anti-Cancer Chemotherapy for Colorectal Cancer — NCD 291 \| CMS Coverage Update	CMS	Modified	Oncology	Mar 12, 2026
PET for Perfusion of the Heart — NCD 292 \| CMS Coverage Update	CMS	Modified	Cardiology	Mar 12, 2026
FDG PET for Esophageal Cancer (Replaced with Section 220.6.17) - RETIRED — NCD 293 \| CMS Coverage Update	CMS	Modified	Oncology	Mar 12, 2026
FDG PET for Refractory Seizures — NCD 294 \| CMS Coverage Update	CMS	Modified	Neurology & Neurosurgery	Mar 12, 2026
FDG PET for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and Testicular Cancers (Replaced with Section 220.6.17) - RETIRED — NCD 295 \| CMS Coverage Update	CMS	Modified	Oncology, Orthopedics & Spine, Neurology & Neurosurgery, Gastroenterology, Pulmonology	Mar 12, 2026
FDG PET for All Other Cancer Indications Not Previously Specified (Replaced with Section 220.6.17) - RETIRED — NCD 296 \| CMS Coverage Update	CMS	Modified	Oncology	Mar 12, 2026
FDG PET for Breast Cancer (Replaced with Section 220.6.17) - RETIRED — NCD 297 \| CMS Coverage Update	CMS	Modified	Oncology	Mar 12, 2026
FDG PET for Myocardial Viability — NCD 298 \| CMS Coverage Update	CMS	Modified	Cardiology	Mar 12, 2026
FDG PET for Colorectal Cancer (Replaced with Section 220.6.17) - RETIRED — NCD 299 \| CMS Coverage Update	CMS	Modified	Oncology	Mar 12, 2026
Manipulation — NCD 3 \| CMS Coverage Update	CMS	Modified	Orthopedics & Spine	Mar 12, 2026
Chemical Aversion Therapy for Treatment of Alcoholism — NCD 30 \| CMS Coverage Update	CMS	Modified	Behavioral Health	Mar 12, 2026
FDG PET for Lymphoma (Replaced with Section 220.6.17) - RETIRED — NCD 300 \| CMS Coverage Update	CMS	Modified	Oncology	Mar 12, 2026
FDG PET for Lung Cancer (Replaced with Section 220.6.17) - RETIRED — NCD 301 \| CMS Coverage Update	CMS	Modified	Oncology, Pulmonology	Mar 12, 2026

Payer policy changesfor billing and compliance teams.

One missed policy change can cost thousands in denied claims.

Payer policy changes
for billing and compliance teams.